(Q47388093)

15 January 2018

title

The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer (English)

1 reference

15 January 2018

intraepithelial neoplasia

main subject

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

prostatic intraepithelial neoplasia

1 reference

Vallbo C

1

1 reference

15 January 2018

Wang W

series ordinal

2

1 reference

15 January 2018

Damber JE

series ordinal

3

1 reference

15 January 2018

publication date

1 June 2004

1 reference

15 January 2018

published in

BJU International

1 reference

15 January 2018

volume

93

1 reference

15 January 2018

issue

9

1 reference

15 January 2018

page(s)

1339-1343

1 reference

15 January 2018

Angiogenesis in cancer and other diseases

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

The functions of thrombospondin-1 and-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Matrix-bound thrombospondin promotes angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04818.X

10.1111/J.1464-410X.2004.04818.X

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018